Adult phenotype of genetically confirmed Dravet syndrome: diagnostic challenges and clinical red flags from a multicenter Polish cohort

AIM OF THE STUDY: To characterize the clinical phenotype of adults with clinically diagnosed and genetically confirmed Dravet syndrome (DS), with particular emphasis on seizure evolution, cognitive and motor impairment, and diagnostic delay. CLINICAL RATIONALE FOR THE STUDY: An increasing number of individuals with DS survive into adulthood and require long-term neurological care. However, the adult phenotype differs from the classical childhood presentation and remains underrecognized in adult neurological practice. Recognition of an age-evolving seizure phenotype, together with intellectual disability, gait and postural abnormalities, and extrapyramidal features, may provide important diagnostic clues and prompt molecular testing in previously undiagnosed adults. MATERIAL AND METHODS: We conducted a multicenter retrospective case series of nine adults (six females and three males) fulfilling clinical diagnostic criteria for DS and carrying a pathogenic or likely pathogenic SCN1A variant. Clinical data were obtained from medical records, neurological examinations, seizure diaries, and psychological assessments performed as part of routine care. Seizure history and evolution, status epilepticus, cognitive and communication impairment, motor phenotype, and treatment history were analyzed. RESULTS: The mean age at evaluation was 27.8 years (range 21-37 years). Seizure onset occurred at a mean age of 6 months, whereas the mean age at molecular diagnosis was 13.2 years, corresponding to a mean diagnostic delay of 12.7 years. Febrile seizures occurred in eight of nine patients and persisted beyond the age of 18 years in three. Generalized tonic-clonic seizures persisted into adulthood in all patients, whereas status epilepticus occurred after the age of 18 years in only one. Intellectual disability was present in all patients and was severe or profound in six; communication impairment was observed in eight. Motor abnormalities were prominent, including gait impairment (9/9), ataxia (8/9), postural abnormalities (8/9), bradykinesia (5/9), hypomimia (5/9), and parkinsonian features (3/9). All patients had been exposed to sodium channel-blocking antiseizure medications before molecular diagnosis, with seizure worsening documented in eight of nine patients. CONCLUSIONS AND CLINICAL IMPLICATIONS: The adult phenotype of DS combines persistent drug-resistant epilepsy with intellectual and communication impairment and prominent motor dysfunction. Although generalized tonic-clonic seizures may persist, other features of the epileptic phenotype, particularly status epilepticus, become less prominent with age. Gait, postural, cerebellar, and extrapyramidal abnormalities may provide important diagnostic clues in adults with infantile-onset epilepsy and intellectual disability. Recognition of this age-evolving phenotype may facilitate molecular diagnosis and support syndrome-specific management in adult neurological practice.

Authors

Institutions

Publication Details

Journal
Neurologia i Neurochirurgia Polska
Published
2026-11-16
DOI
https://doi.org/10.5603/pjnns.113442
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adult phenotype of genetically confirmed Dravet syndrome: diagnostic challenges and clinical red flags from a multicenter Polish cohort

Magdalena Badura‐Stronka, Magdalena Krygier, Marta Zawadzka, Ewa Nagańska et al.
Neurologia i Neurochirurgia Polska
Epilepsy research and treatment
article

Adult phenotype of genetically confirmed Dravet syndrome: diagnostic challenges and clinical red flags from a multicenter Polish cohort

Magdalena Badura‐Stronka, Magdalena Krygier, Marta Zawadzka, Ewa Nagańska, Dorota Hoffman-Zacharska, Natasza Wiktor, Maria Mazurkiewicz-Bełdzińska, Anna Winczewska-Wiktor, Barbara Steinborn
article en

Abstract

AIM OF THE STUDY: To characterize the clinical phenotype of adults with clinically diagnosed and genetically confirmed Dravet syndrome (DS), with particular emphasis on seizure evolution, cognitive and motor impairment, and diagnostic delay. CLINICAL RATIONALE FOR THE STUDY: An increasing number of individuals with DS survive into adulthood and require long-term neurological care. However, the adult phenotype differs from the classical childhood presentation and remains underrecognized in adult neurological practice. Recognition of an age-evolving seizure phenotype, together with intellectual disability, gait and postural abnormalities, and extrapyramidal features, may provide important diagnostic clues and prompt molecular testing in previously undiagnosed adults. MATERIAL AND METHODS: We conducted a multicenter retrospective case series of nine adults (six females and three males) fulfilling clinical diagnostic criteria for DS and carrying a pathogenic or likely pathogenic SCN1A variant. Clinical data were obtained from medical records, neurological examinations, seizure diaries, and psychological assessments performed as part of routine care. Seizure history and evolution, status epilepticus, cognitive and communication impairment, motor phenotype, and treatment history were analyzed. RESULTS: The mean age at evaluation was 27.8 years (range 21-37 years). Seizure onset occurred at a mean age of 6 months, whereas the mean age at molecular diagnosis was 13.2 years, corresponding to a mean diagnostic delay of 12.7 years. Febrile seizures occurred in eight of nine patients and persisted beyond the age of 18 years in three. Generalized tonic-clonic seizures persisted into adulthood in all patients, whereas status epilepticus occurred after the age of 18 years in only one. Intellectual disability was present in all patients and was severe or profound in six; communication impairment was observed in eight. Motor abnormalities were prominent, including gait impairment (9/9), ataxia (8/9), postural abnormalities (8/9), bradykinesia (5/9), hypomimia (5/9), and parkinsonian features (3/9). All patients had been exposed to sodium channel-blocking antiseizure medications before molecular diagnosis, with seizure worsening documented in eight of nine patients. CONCLUSIONS AND CLINICAL IMPLICATIONS: The adult phenotype of DS combines persistent drug-resistant epilepsy with intellectual and communication impairment and prominent motor dysfunction. Although generalized tonic-clonic seizures may persist, other features of the epileptic phenotype, particularly status epilepticus, become less prominent with age. Gait, postural, cerebellar, and extrapyramidal abnormalities may provide important diagnostic clues in adults with infantile-onset epilepsy and intellectual disability. Recognition of this age-evolving phenotype may facilitate molecular diagnosis and support syndrome-specific management in adult neurological practice.

Neurologia i Neurochirurgia Polska
Poznan University of Medical Sciences (PL), University of Padua (IT), Instytut Matki i Dziecka (PL), University of Warsaw (PL), Gdańsk Medical University (PL)
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon